EUVIMEDEUVIMED entdecken
Crossref

The Association of BRAF Single Nucleotide Polymorphism (rs113488022) with Clinical Characteristics and Postoperative Outcomes of Craniopharyngioma

Sara Hanaei, Arezou Rezaei, Maryam Sadr, Farid Azmoudeh Ardalan, Seyed Mousa Sadrehosseini, Nima Rezaei, Mehdi Zeinalizadeh

Immunology and Genetics Journal · 18.07.2026

DOI: 10.18502/igj.v9i2.22045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology and Genetics Journal, online erschienen am 18.07.2026. Verfasst von Sara Hanaei und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Craniopharyngiomas are benign but locally aggressive sellar tumors with high postoperative mor- bidity. The BRAF V600E mutation is a hallmark of the papillary subtype, yet its prognostic significance remains controversial. Most studies have focused on papillary craniopharyngiomas, while the potential role of BRAF gene variations in clinical outcomes across both subtypes has been underexplored. This study investigated the association of BRAF single nucleotide polymorphism with clinical characteristics and postoperative outcomes in patients with craniopharyngioma.

Methods

The current historical cohort study included 47 patients with histopathologically confirmed craniophar- yngioma who underwent endoscopic endonasal resection. BRAF rs113488022 genotyping (TT, TC, CC) was per- formed on DNA extracted from formalin-fixed paraffin-embedded tumor specimens using real-time PCR. Associa- tions between genotypes and histopathological subtype, tumor volume, calcification, lobulation, extent of resection, postoperative complications, recurrence, and mortality were analyzed.

Results

The patients included 26 males (55.3%) and 21 females (44.7%), with a mean age of 25.06 ± 17.17 years. The most frequent BRAF rs113488022 genotype was 'TC' (76.6%), followed by 'CC' (14.9%) and 'TT' (8.6%). A sig- nificant difference in genotype distribution was observed between adamantinomatous and papillary craniopharyn- giomas (P=0.024), with the 'CC' genotype being more common in the papillary subtype. No significant associations were found between BRAF rs113488022 genotypes and tumor volume (P=0.93), calcification (P=0.61), lobulation (P=0.34), extent of resection (P=0.47), recurrence (P=0.55), mortality (P=0.13), or postoperative complications in- cluding diabetes insipidus, visual changes, and BMI changes (all P>0.05).

Conclusion

While BRAF rs113488022 genotype distribution differs significantly between histopathological sub- types and serves as a valuable diagnostic marker, it does not independently predict postoperative surgical outcomes, recurrence, or mortality in craniopharyngioma patients. Larger prospective studies are needed to further elucidate the prognostic significance of specific BRAF SNPs

Zitieren

APA

Hanaei, S., Rezaei, A., Sadr, M., Ardalan, F. A., Sadrehosseini, S. M., Rezaei, N., & Zeinalizadeh, M. (2026). The Association of BRAF Single Nucleotide Polymorphism (rs113488022) with Clinical Characteristics and Postoperative Outcomes of Craniopharyngioma. Immunology and Genetics Journal. https://doi.org/10.18502/igj.v9i2.22045

Vancouver

Hanaei S, Rezaei A, Sadr M, Ardalan FA, Sadrehosseini SM, Rezaei N, et al. The Association of BRAF Single Nucleotide Polymorphism (rs113488022) with Clinical Characteristics and Postoperative Outcomes of Craniopharyngioma. Immunology and Genetics Journal. 2026. doi:10.18502/igj.v9i2.22045

BibTeX
@article{Hanaei2026,
  author = {Hanaei, Sara and Rezaei, Arezou and Sadr, Maryam and Ardalan, Farid Azmoudeh and Sadrehosseini, Seyed Mousa and Rezaei, Nima and Zeinalizadeh, Mehdi},
  title = {The Association of BRAF Single Nucleotide Polymorphism (rs113488022) with Clinical Characteristics and Postoperative Outcomes of Craniopharyngioma},
  journal = {Immunology and Genetics Journal},
  year = {2026},
  doi = {10.18502/igj.v9i2.22045}
}
Kostenlos starten →